BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 30213751)

  • 1. Magnetic Resonance Imaging Evaluation of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy: Long Term Imaging Follow-Up.
    Mendiratta-Lala M; Masch W; Shankar PR; Hartman HE; Davenport MS; Schipper MJ; Maurino C; Cuneo KC; Lawrence TS; Owen D
    Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):169-179. PubMed ID: 30213751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging Findings Within the First 12 Months of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy.
    Mendiratta-Lala M; Gu E; Owen D; Cuneo KC; Bazzi L; Lawrence TS; Hussain HK; Davenport MS
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1063-1069. PubMed ID: 29029891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of hepatocellular carcinoma after stereotactic body radiation therapy.
    Mendiratta-Lala M; Masch W; Owen D; Aslam A; Maurino C; Devasia T; Schipper MJ; Parikh ND; Cuneo K; Lawrence TS; Davenport MS
    Abdom Radiol (NY); 2020 Nov; 45(11):3698-3708. PubMed ID: 32303772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response evaluation of hepatocellular carcinoma treated with stereotactic body radiation therapy: magnetic resonance imaging findings.
    Mai Z; Yang Q; Xu J; Xie H; Ban X; Xu G; Zhang R
    Abdom Radiol (NY); 2023 Jun; 48(6):1995-2007. PubMed ID: 36939911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal assessment of hepatocellular carcinoma response to stereotactic body radiation using gadoxetate-enhanced MRI: A case series.
    Sharma HK; Kyriakakos C; Jabbour TE; Ward S; Buckstein M; Taouli B; Lewis S
    Eur J Radiol; 2023 Oct; 167():111077. PubMed ID: 37688918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy With Radiologic-Pathologic Explant Correlation in Patients With SBRT-Treated Hepatocellular Carcinoma.
    Mendiratta-Lala M; Aslam A; Maturen KE; Westerhoff M; Maurino C; Parikh ND; Sun Y; Sonnenday CJ; Stein EB; Shampain KL; Kaza RK; Cuneo K; Masch W; Do RKG; Lawrence TS; Owen D
    Int J Radiat Oncol Biol Phys; 2022 Mar; 112(3):704-714. PubMed ID: 34644607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor response assessment by MRI following stereotactic body radiation therapy for hepatocellular carcinoma.
    Oldrini G; Huertas A; Renard-Oldrini S; Taste-George H; Vogin G; Laurent V; Salleron J; Henrot P
    PLoS One; 2017; 12(4):e0176118. PubMed ID: 28441447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging post-stereotactic body radiation therapy responses for hepatocellular carcinoma: typical imaging patterns and pitfalls.
    Mastrocostas K; Jang HJ; Fischer S; Dawson LA; Munoz-Schuffenegger P; Sapisochin G; Kim TK
    Abdom Radiol (NY); 2019 May; 44(5):1795-1807. PubMed ID: 30710166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local Tumor Control and Patient Outcome Using Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: iRECIST as a Potential Substitute for Traditional Criteria.
    Vernuccio F; Godfrey D; Meyer M; Williamson HV; Salama JK; Niedzwiecki D; Stephens SJ; Ronald J; Palta M; Marin D
    AJR Am J Roentgenol; 2019 Dec; 213(6):1232-1239. PubMed ID: 31613663
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation.
    O'Connor JK; Trotter J; Davis GL; Dempster J; Klintmalm GB; Goldstein RM
    Liver Transpl; 2012 Aug; 18(8):949-54. PubMed ID: 22467602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Accuracy of Image-Guided Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Real-Life Clinical Practice: In Vivo Assessment Using Hepatic Parenchymal Changes on Gd-EOB-DTPA-Enhanced Magnetic Resonance Images.
    Jung J; Kim H; Yoon SM; Cho B; Kim YJ; Kwak J; Kim JH
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):867-874. PubMed ID: 29934276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic reaction dose for parenchymal changes on Gd-EOB-DTPA-enhanced magnetic resonance images after stereotactic body radiation therapy for hepatocellular carcinoma.
    Jung J; Yoon SM; Cho B; Choi YE; Kwak J; Kim SY; Lee SW; Ahn SD; Choi EK; Kim JH
    J Med Imaging Radiat Oncol; 2016 Feb; 60(1):96-101. PubMed ID: 26503671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiation therapy for early hepatocellular carcinoma: a retrospective analysis of the South Australian experience.
    Wigg AJ; Narayana SK; Le H; Iankov I; Chinnaratha MA; Tse E; Chen JW; Gowda R
    ANZ J Surg; 2019 Sep; 89(9):1138-1143. PubMed ID: 30983104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiation therapy as a salvage treatment for single viable hepatocellular carcinoma at the site of incomplete transarterial chemoembolization: a retrospective analysis of 302 patients.
    Lee S; Jung J; Park JH; Kim SY; Choi J; Lee D; Shim JH; Kim KM; Lim YS; Lee HC; Park HH; Kim JH; Yoon SM
    BMC Cancer; 2022 Feb; 22(1):175. PubMed ID: 35172769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiological tumor response and histopathological correlation of hepatocellular carcinoma treated with stereotactic body radiation therapy as a bridge to liver transplantation.
    Mastrocostas K; Fischer S; Munoz-Schuffenegger P; Jang HJ; Dawson LA; Liu ZA; Sapisochin G; Kim TK
    Abdom Radiol (NY); 2021 Apr; 46(4):1572-1585. PubMed ID: 33074426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma.
    Moore A; Cohen-Naftaly M; Tobar A; Kundel Y; Benjaminov O; Braun M; Issachar A; Mor E; Sarfaty M; Bragilovski D; Hur RB; Gordon N; Stemmer SM; Allen AM
    Radiat Oncol; 2017 Oct; 12(1):163. PubMed ID: 29052532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic Body Radiation Therapy: A New Strategy for Loco-Regional Treatment for Hepatocellular Carcinoma While Awaiting Liver Transplantation.
    Uemura T; Kirichenko A; Bunker M; Vincent M; Machado L; Thai N
    World J Surg; 2019 Mar; 43(3):886-893. PubMed ID: 30361748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic body radiation therapy using a respiratory-gated volumetric-modulated arc therapy technique for small hepatocellular carcinoma.
    Jeong Y; Jung J; Cho B; Kwak J; Jeong C; Kim JH; Park JH; Kim SY; Shim JH; Kim KM; Lim YS; Lee HC; Yoon SM
    BMC Cancer; 2018 Apr; 18(1):416. PubMed ID: 29653562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SBRT for HCC: Overview of technique and treatment response assessment.
    Shampain KL; Hackett CE; Towfighi S; Aslam A; Masch WR; Harris AC; Chang SD; Khanna K; Mendiratta V; Gabr AM; Owen D; Mendiratta-Lala M
    Abdom Radiol (NY); 2021 Aug; 46(8):3615-3624. PubMed ID: 33963419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
    Su TS; Lu HZ; Cheng T; Zhou Y; Huang Y; Gao YC; Tang MY; Jiang HY; Lian ZP; Hou EC; Liang P
    BMC Cancer; 2016 Nov; 16(1):834. PubMed ID: 27809890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.